Considered to be one of the greatest revolutions in cancer treatment, immunotherapy enhances the immune system's ability to ...

A new study found that the immunotherapy treatment worked against some types of cancers, allowing patients to avoid surgery ...

Company currently initiating additional trial sites and working with study investigators to enroll participants IMNN-001 is the first and only immunotherapy to show meaningful overall survival benefit ...

Spill, who has no family history of colorectal cancer, was among more than 100 adults in the United States who completed cancer treatment in a new study using only the immunotherapy drug ...

A team of researchers from Moffitt Cancer Center has found new insight into why some lung cancer patients do not benefit from ...

According to the results of a new study in the New England Journal of Medicine, 92% of patients who took this drug were cancer-free after two years.

A team of researchers has found new insight into why some lung cancer patients do not benefit from tumor-infiltrating lymphocyte, or TIL therapy. Their findings may help improve future ways to deliver ...

The researchers conducted a retrospective cohort study with data from 1003 patients, aged less than 1 year to 47 years, who underwent oral immunotherapy for peanut, tree nut, milk, egg ...

enhancing immunotherapy treatments for better outcomes in patients. "This study has huge implications in reversing the resistance of cancer patients to various immunotherapies," Verma said.

Newly discovered oncology drugs called “DNA-encoded tri-specific T-cell engagers,” or “DTriTEs,” engage the immune system ...

This part of the Phase II study evaluates eftilagimod alfa (efti ... Up to 20% of 1L HNSCC patients have CPS <1 and despite immunotherapy’s progress in fighting cancer, anti-PD-1 therapy ...